Back to search

University of British Columbia

Enhancement of the GluN2B subtype of n-methyl-d-aspartate glutamate receptor for memory improvement

Abstract

dc:description

The N-methyl-D-aspartate glutamate receptors (NMDAR) containing the GluN2B subunit are important for synaptic plasticity and various types of learning and memory. It has been shown that disrupting the function of GluN2B using genetic knockout or pharmacological inhibitors impaired activity-dependent synaptic plasticity and memory performances in rodents, whereas genetic enhancement of GluN2B expression in cortical neurons of rodents enhanced synaptic plasticity and learning. Based on these findings, we hypothesize that pharmacological enhancement of the GluN2B-NMDAR function will facilitate NMDAR-dependent synaptic plasticity and hence learning and memory in wildtype rats. To test our hypothesis, we identified GluN2B-NMDAR-specific positive allosteric modulators using computer-assisted virtual high throughput screening combined with in vitro drug screening assays measuring their NMDAR modulatory activities. We then optimized the potency and GluN2B-selectivity of our hit compounds using structural-based approaches, which led to the development of lead modulators with ~50 nanomolar potency on GluN2B-NMDAR and over 50-fold selectivity against GluN2A and other NMDAR subtypes. Using a combination of electrophysiology and molecular biology techniques, we further characterized the pharmacological properties and the binding site of the lead compounds. Following that, we conducted in vivo functional studies using our blood-brain barrier penetrant lead compound 175. We found that systemic administration of 175 facilitated bidirectional synaptic plasticity in the dorsal hippocampus of anesthetized rats. We next provided initial evidence that 175 administrations facilitated learning in rats using a novel object recognition test. Overall, our studies developed the first potent and selective GluN2B-NMDAR positive allosteric modulator and suggested the possibility for the wide-ranging in vivo application of the drug as a research tool and a treatment for cognitive deficits in neurological diseases.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Neuroscience
Grantor dc:publisher
University of British Columbia
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ge, Yang
Contributors dc:contributor
  • Wang, Yu Tian

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/83602

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ge, Yang. Enhancement of the GluN2B subtype of n-methyl-d-aspartate glutamate receptor for memory improvement. doctoral thesis, University of British Columbia, 2022. http://hdl.handle.net/2429/83602